Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Immunology
Published in: BMC Immunology 1/2015

Open Access 01-12-2015 | Research article

Elevated levels of dehydroepiandrosterone as a potential mechanism of dendritic cell impairment during pregnancy

Authors: Elena R Chernykh, Olga Yu Leplina, Marina A Tikhonova, Nataliya V Seledtsova, Tamara V Tyrinova, Nataliya A Khonina, Alexandr A Ostanin, Nataliya M Pasman

Published in: BMC Immunology | Issue 1/2015

Login to get access

Abstract

Background

This study aimed to test the hypothesis that immune dysfunction and the increased risk of spontaneous abortion in pregnant women with hyperandrogenia (HA) are caused by the reduced tolerogenic potential of dendritic cells (DCs) that results from elevated levels of dehydroepiandrosterone sulfate (DHEAS).

Methods

The phenotypic and functional properties of monocyte-derived DCs generated from blood monocytes from non-pregnant women, women with a normal pregnancy, or pregnant women with HA, as well as the in vitro effects of DHEAS on DCs in healthy pregnant women were investigated.

Results

In a normal pregnancy, DCs were shown to be immature and are characterized by a reduced number of CD83+ and CD25+ DCs, the ability to stimulate type 2 T cell responses and to induce T cell apoptosis. By contrast, DCs from pregnant women with HA had a mature phenotype, were able to stimulate both type 1 (IFN-γ) and type 2 (IL-4) T cell responses, and were characterized by lower B7-H1 expression and cytotoxic activity against CD8+ T cells. The addition of DHEAS to cultures of DCs from healthy pregnant women induced the maturation of DCs and increased their ability to activate type 1 T cell responses.

Conclusion

Our data demonstrated the reduction in the tolerogenic potential of DCs from pregnant women with HA, and revealed new mechanisms involved in the hormonal regulation of DCs mediated by DHEAS.
Literature
1.
Medawar PB. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp Soc Exp Biol. 1953;44:320–38.
2.
Taglauer ES, Adams Waldorf KM, Petroff MG. The hidden maternal-fetal interface: events involving the lymphoid organs in maternal-fetal tolerance. Int J Dev Biol. 2010;54(2–3):421–30.CrossRefPubMedCentralPubMed
3.
Guleria I, Sayegh MH. Maternal acceptance of the fetus: true human tolerance. J Immunol. 2007;178(6):3345–51.CrossRefPubMed
4.
James E, Chai JG, Dewchand H, Macchiarulo E, Dazzi F, Simpson E. Multiparity induces priming tomale-specific minor histocompatibility antigen, HY, in mice and humans. Blood. 2003;102:388–93.CrossRefPubMed
5.
Jiang SP, Vacchio MS. Multiple mechanisms of peripheral T cell tolerance to the fetal «allograft». J Immunol. 1998;160:3086–90.PubMed
6.
Guerin LR, Prins JR, Robertson SA. Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? Hum Reprod. 2009;15(5):517–35.CrossRef
7.
Kushwah R, Hu J. Role of dendritic cells in the induction of regulatory T cells. Cell Biosci. 2011;1:1–20.CrossRef
8.
Raghupathy R. Pregnancy: success and failure within the Th1/Th2/Th3 paradigm. Semin Immunol. 2001;13:219–27.CrossRefPubMed
9.
Sykes L, MacIntyre DA, Yap XJ, Teoh TG, Bennett PR: The Th1:Тh2 dichotomy of pregnancy and preterm labour. Mediators Inflamm 2012, 967629. doi:10.1155/2012/967629
10.
Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767–811.CrossRefPubMed
11.
Adams S, O’Neill DW, Bhardwaj N. Recent advances in dendritic cell biology. J Clin Immunol. 2005;25:177–88.PubMed
12.
Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol. 2003;21:685–711.CrossRefPubMed
13.
Kuwana M, Kaburaki J, Wright TM, Kawakami Y, Ikeda Y. Induction of antigen-specific human CD4(+) T cell anergy by peripheral blood DC2 precursors. Eur J Immunol. 2001;31:2547–57.CrossRefPubMed
14.
Lutz M: Therapeutic potential of semi-mature dendritic cells for tolerance induction. Front.Immunol. doi: 10.3389/fimmu.2012.00123
15.
Rutella S, Danese S, Leone G. Tolerogenic dendritic cells: Cytokine modulation comes of age. Blood. 2006;108:1435–40.CrossRefPubMed
16.
17.
Gregori S. Dendritic cells in networks of immunological tolerance. Tissue Antigens. 2010;77:89–99.CrossRef
18.
19.
20.
Guo PF, Du MR, Wu HX, Lin Y, Jin LP, Li DJ. Thymic stromal lymphopoietin from trophoblasts induces dendritic cell-mediated regulatory TH2 bias in the decidua during early gestation in humans. Blood. 2010;116:2061–9.CrossRefPubMed
21.
Adams KM, Yan Z, Stevens AM, Nelson JL. The changing maternal «self» hypothesis: a mechanism for maternal tolerance of the fetus. Placenta. 2007;28:378–82.CrossRefPubMed
22.
Liang J, Sun L, Wang Q. Progesterone regulates mouse dendritic cells differentiation and maturation. Int Immunopharmacol. 2006;6:350–5.CrossRef
23.
Segerer SE, Meller N, van den Brandt J, Kapp M, Dietl J. Modulation of maturation and function of dendritic cells by female sex steroid hormones. Amer J Reprod Immunol. 2008;60:86–96.CrossRef
24.
Matasiс R, Dietz AB, Vuk-Pavloviс S. Dexamethasone inhibits dendritic cell maturation by redirecting differentiation of a subset of cells. J Leukoc Biol. 1999;66(6):909–14.
25.
Wan H, Versnel MA, Leijten LM, van Helden-Meeuwsen CG, Fekkes D. Modulation of maturation and function of dendritic cells by female sex steroid hormones Chorionic gonadotropin induces dendritic cells to express a tolerogenic phenotype. J Leukoc Biol. 2008;83(4):894–901.CrossRefPubMed
26.
27.
Butts CL, Candando KM, Warfel J, Belyavskaya E, D'Agnillo F, Sternberg EM. Progesterone regulation of uterine dendritic cell function in rodents is dependent on the stage of estrous cycle. Mucosal Immunol. 2010;3(5):496–505.CrossRefPubMed
28.
Blois SM, Kammerer U, Alba Soto C, Tometten MC, Shaikly V, Barrientos G, et al. Dendritic cells: key to fetal tolerance? Biol Reprod. 2007;77:590–8.CrossRefPubMed
29.
Seledtsova NV, Khonina NA, Dudareva AV, Tihonova MA, Ostanin AA, Pasman NM, et al. Characteristic of natural cytotoxic cells and regulatory T-lymphocytes in pregnant women with hyperandrogenia. Immunology. 2007;3:151–5 (in Russian).
30.
Winger EE, Reed JL. Low circulating CD4+CD25+Foxp3+ T regulatory cell levels predict miscarriage risk in newly pregnant women with a history of failure. Am J Reprod Immunol. 2011;66:320–8.CrossRefPubMed
31.
Shakhar K, Rosenne E, Loewenthal R, Shakhar G, Carp H, Ben-Eliyahu S. High NK cell activity in recurrent miscarriage: what are we really measuring? Hum Reprod. 2006;21(9):2421–5.CrossRefPubMed
32.
Moran C, Azziz R, Weintrob N, Witchel SF, Rohmer V, Dewailly D, et al. Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia. J Clin Endocrinol Metabolism. 2006;91(9):3451–6.CrossRef
33.
Gurbuz B, Yalti S, Fiçicioglu C, Ozden S, Yildirim G, Sayar C. Basal hormone levels in women with recurrent pregnancy loss. Gynecol Endocrinol. 2003;17(4):317–21.CrossRefPubMed
34.
Powell JM, Sonnenfeld G. The effects of Dehydroepiandrosterone (DHEA) on in vitro spleen cell proliferation and cytokine production. J Interferon Cytokine Res. 2006;26(1):34–9.CrossRefPubMed
35.
Seledtsova NV, Khonina NA, Tikhonova MA, Ostanin AA, Pasman NМ, Chernykh ER. Effect of dehydroepiandrosterone sulfate on the phenotype and functions of dendritic cells in vitro. Med Immunol. 2007;9(6):589–96 (in Russian).
36.
Tyrinova TV, Leplina OY, Tikhonova MA, Sakhno LV, Ostanin AA, Chernykh ER. Characteristics of signaling pathways mediating a cytotoxic activity of dendritic cells upon activated T lymphocytes and NK cells. Med Immunol. 2012;14(1–2):43–50 (in Russian).
37.
Sakhno LV, Tikhonova MA, Tyrinova TV, Leplina OY, Shevela EY at al: Cytotoxic Activity of Dendritic Cells as a Possible Mechanism of Negative Regulation of T Lymphocytes in Pulmonary Tuberculosis. Clinical and Developmental Immunology 2012, Article ID 628635, 9. doi:10.1155/2012/628635
38.
Kammerer U, Kruse A, Barrientos G, Arck PC, Blois SM. Role of dendritic cells in the regulation of maternal immune responses to the fetus during mammalian gestation. Immunol Invest. 2008;37(5):499–533.CrossRefPubMed
39.
Askelund K, Liddell HS, Zanderigo AM, Fernando NS, Khong TY, Stone PR, et al. CD83(+) dendritic cells in the decidua of women with recurrent miscarriage and normal pregnancy. Placenta. 2004;25:140–5.CrossRefPubMed
40.
Thurner B, Roder C, Dieckmann D, Heuer M, Kruse M, Glaser A, et al. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical applications. J Immunol Meth. 1999;223:1–15.CrossRef
41.
Santini S, Pucchini T, Lapenta C, Parlato S, Logozzi M, Belardelli F, et al. A new type 1 IFN-mediated pathway for the rapid differentiation of monocytes into highly active dendritic cells. Stem Cells. 2003;21:357–62.CrossRefPubMed
42.
Tabata N, Tagami H, Terui T. Dehydroepiandrosterone may be one of the regulators of cytokine production in atopic dermatitis. Arch Dermatol Res. 1997;289(7):410–4.CrossRefPubMed
43.
Santini S, Lapenta C, Logozzi M, Parlato S, Spada M, Pucchio T, et al. Type I Interferon as a powerful adjuvant for monocyte-derived dendritic cells development and activity in vitro and in HU-PBL-SCID mice. J Exp Med. 2000;191:1777–88.CrossRefPubMedCentralPubMed
44.
Della Bella S, Nicola S, Riva A, Biasin M, Clerici M, Villa ML. Functional repertoire of dendritic cells generated in granulocyte macrophage-colony stimulating factor and interferon–α. J Leukocyte Biol. 2004;75:106–16.CrossRefPubMed
45.
Papewalis C, Jacobs B, Wuttke M, Ullrich E, Baehring T, Fenk R, et al. IFN-a skews monocytes into CD56 + -expressing dendritic cells with potent functional activities in vitro and in vivo. J Immunol. 2008;80(3):1462–70.CrossRef
46.
47.
Ban YL, Kong BH, Qu X, Yang QF, Ma YY. BDCA-1+, BDCA-2+ and BDCA-3+ dendritic cells in early human pregnancy deciduas. Clin Exp Immunol. 2008;151:399–406.CrossRefPubMedCentralPubMed
48.
Miyazaki S, Tsuda H, Sakai M, Hori S, Sasaki Y, Futatani T, et al. Predominance of Th2-promoting dendritic cells in early human pregnancy decidua. J Leukoc Biol. 2003;74:514–22.CrossRefPubMed
49.
Della Bella S, Giannelli S, Cozzi V, Signorelli V, Cappelletti M, et al. Incomplete activation of peripheral blood dendritic cells during healthy human pregnancy. Clin Exp Immunol. 2011;164(2):180–92.CrossRefPubMedCentralPubMed
50.
Bachy V, Williams DJ, Ibrahim MA. Altered dendritic cell function in normal pregnancy. J Reprod Immunol. 2008;78(1):11–21.CrossRefPubMed
51.
Leplina O, Yu Tikhonova MA, Tyrinova TV, Alyamkina EA, Dolgova EV, Bogachev SS, et al. Comparative characteristic of phenotype and cytokine-secretory activity of human dendritic cells generated in vitro with IFN-alpha and IL-4. Immunology. 2012;33(2):60–5. in Russian).
52.
Seledtsova NV, Khonina NA, Tihonova MA, Pasman NM, Ostanin AA, Chernykh RR, et al. The interaction of NK-cells with dendritic cells modified by dehydroepiandrosterone sulfate. Immunology. 2008;2:80–4 (in Russian).
53.
Huang SJ, Chen CP, Schatz F, Rahman M, Abrahams VM, Lockwood CJ. Pre-eclampsia is associated with dendritic cell recruitmnt into the uterine decidua. J Pathol. 2008;214:328–36.CrossRefPubMed
Metadata
Title
Elevated levels of dehydroepiandrosterone as a potential mechanism of dendritic cell impairment during pregnancy
Authors
Elena R Chernykh
Olga Yu Leplina
Marina A Tikhonova
Nataliya V Seledtsova
Tamara V Tyrinova
Nataliya A Khonina
Alexandr A Ostanin
Nataliya M Pasman
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Immunology / Issue 1/2015
Electronic ISSN: 1471-2172
DOI
https://doi.org/10.1186/s12865-014-0065-9

Other articles of this Issue 1/2015

BMC Immunology 1/2015 Go to the issue

Research article

Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM

Research article

CXCL13 antibody for the treatment of autoimmune disorders

Research article

Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis

Review

The genetic control of immunity to Plasmodium infection

Research article

Soluble RANKL expression in Lactococcus lactis and investigation of its potential as an oral vaccine adjuvant

Research article

PHF11 expression and cellular distribution is regulated by the Toll-Like Receptor 3 Ligand Polyinosinic:Polycytidylic Acid in HaCaT keratinocytes

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits